Bio: John Kershaw’s career with Sysmex Corporation, Kobe, Japan, began as a result of the company’s acquisition of L.E.P. Scientific in 1991. During his tenure, Kershaw has held several leadership positions with the company, including Vice President of Sysmex Europe, and Executive Vice President and board member for Sysmex Europe. At that time, he was also appointed to serve as a board member of Sysmex’s software company located in Belgium, Sysmex MOLIS.
As a result of Sysmex’s strategic move to develop the infrastructure and grow the business in the Americas, Kershaw moved to the United States. Here, he became Chief Operating Officer, Managing Director, and a board member of Sysmex’s United States headquarters, Sysmex Corporation of America, now known as Sysmex America. In 2009, he was elevated to the position of President and Chief Executive Officer of Sysmex America, Inc.
In addition to his current duties, in 2014, Kershaw was appointed as an Executive Officer of Sysmex Corporation.
Kershaw’s education is in the areas of hematology, microbiology, biochemistry, immunology, anatomic pathology, and blood transfusion. He is a fellow of the Association of Medical Technologists in the United Kingdom and serves as the company’s representative member of AdvaMed.